pyrvinium has been researched along with Cancer of Prostate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alliston, T; Chin, E; He, M; Jones, JO; Lim, M; Nguyen, D; Otto-Duessel, M; Su, L | 1 |
Adomat, H; Ban, F; Cherkasov, A; Dalal, K; Frewin, K; Leblanc, E; Li, H; Ma, D; Rennie, PS | 1 |
2 other study(ies) available for pyrvinium and Cancer of Prostate
Article | Year |
---|---|
Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.
Topics: Absorptiometry, Photon; Androgen Receptor Antagonists; Animals; Bone Density; Cell Line, Tumor; Computational Biology; HEK293 Cells; Humans; Ligands; Male; Mice; Models, Biological; Molecular Docking Simulation; Prostate; Prostatic Neoplasms; Pyrvinium Compounds; Receptors, Androgen; Xenograft Model Antitumor Assays | 2014 |
Discovery of small-molecule inhibitors selectively targeting the DNA-binding domain of the human androgen receptor.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Benzamides; Binding Sites; Cell Line, Tumor; Cell Survival; Computer Simulation; Databases, Chemical; DNA; Drug Resistance, Neoplasm; Humans; Imidazoles; Male; Molecular Conformation; Molecular Docking Simulation; Morpholines; Mutation; Nitriles; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrvinium Compounds; Rats; Receptors, Androgen; Structure-Activity Relationship; Thiazoles; Thiophenes; Transcription, Genetic | 2014 |